Zdrowie i gospodarka · 10/01/2014
FDA Releases Draft Guidance for Industry on Qualification of Exacerbations of Chronic Pulmonary Disease Tool for Measuring Symptoms of Acute Bacterial Exacerbation of Chronic Bronchitis in Patients with Chronic Obstructive Pulmonary Disease
The Food and Drug Administration (FDA) has made available a draft guidance for industry that outlines the qualification of the Exacerbations of Chronic Pulmonary Disease Tool (EXACT) for measuring symptoms of acute bacterial exacerbation of chronic bronchitis in patients with chronic obstructive pulmonary disease (COPD)
Source: Federal Register — Food and Drug AdministrationOpen original release →